— Ticker · NMS —
REGN · Regeneron Pharmaceuticals, Inc.
Healthcare · Biotechnology
REGN
$634.62
▼ -10.84%
7-day move
7-day move
day$632.76 → $648.5052-wk$476.49 → $821.11avg vol763,315 / 3Mcap$66.5B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 11.8 |
| P/E (trailing) | 15.5 |
| EPS (forward) | $53.77 |
| EPS (trailing) | $40.95 |
| PEG | 1.11 |
| Dividend | 59.00% |
The Risk
| Beta | 0.30 |
| Short % float | 3.30% |
| Float | 97.7M |
| Shares out | 103.0M |
| Avg vol (3M) | 763,315 |
| 52w range | $476.49 → $821.11 |
The Analyst Tape
strong buybuyholdunderperformsell
$833.31
avg 12-mo target
+31.3%
vs. last · 28 analysts
The Pipeline
$66.5B
market cap
exchangeNMS
sectorHealthcare
industryBiotechnology
market cap$66.5B
websiteregeneron.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for REGN in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for REGN.
Other Players in the Pipeline
Biotech · by market cap · 7-day move